Lexington Technology Park is one of the premier locations outside of the Cambridge cluster for Biotech, Pharmaceuticals, and Research Innovation. Located at the intersection of Route 128 and Route 2 – just minutes from Boston, Cambridge, and the largest cluster of technology, healthcare, and educational organizations in the world – Lexington Technology Park is a premier choice for businesses seeking high quality office, research, and manufacturing space. The park’s scenic campus setting, ideal highway access, pre-permitted development sites, and location in one of the state’s fastest growing suburban biotechnology hubs give it a natural competitive advantage over other business locations.
LEXINGTON PARK
High quality office, research, and manufacturing space
Lexington Technology Park is one of the State’s fastest growing suburban biotechnology hubs
About the Project
Patriot Partners
A partnership of leading local development firms Atlantic Management and Mohawk Partners – purchased the 96.5-acre site in 2003. In November 2009, the Town of Lexington enthusiastically endorsed a plan to expand Lexington Technology Park by 380,000-square-feet of space on two development-ready sites. This planned expansion follows a dramatic six-year transformation of the former Raytheon Global Headquarters into a leading regional destination for world-class biotechnology and technology companies. The park is now home to Takeda (formerly Shire) Pharmaceuticals’ Human Genetic Therapies Division, other growing firms, and nearly 40 acres of preserved open space.
680,000
SQ FT up to 1.1 MIL SQ FT
5
BUILDINGS
40
ACRES OF PRESERVED OPEN SPACE
2003
Patriot Partners purchases former Raytheon Global Headquarters.
2004
- Patriot Partners secures Lexington Town Meeting approval to rezone the property for life sciences and high-tech uses, and expand development at the site.
- Construction begins to revitalize existing facilities at Lexington Technology Park.
2006
Patriot Partners begins marketing the park to cutting-edge biotechnology tenants.
2007
- Shire Pharmaceuticals begins relocating its Human Genetic Therapies Division to Lexington Technology Park, supported by a TIF agreement from the Town of Lexington.
- Lexington Town Meeting members approve Patriot Partners’ expanded redevelopment plans for Lexington Technology Park, paving the way for a $394 million capital investment by Shire in the site’s existing facilities and the construction of several additional buildings.
2008
Shire breaks ground on its first new building at Lexington Technology Park.
2009
Lexington Town Meeting endorses an additional 380,000-square-feet of development at Lexington Technology Park on two development sites. At build-out, the Park will generate $2.2 million in annual new tax revenues for the Town.
2010
Patriot Partners sells Lexington Technology Park to Shire for $201 million.
